Use of a pyrazole derivative in the treatment of acute exacerbations of chronic obstructive pulmonary disease
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 17, 2016
Issued Date -
N/A
app pub date -
Mar 19, 2013
filing date -
Mar 20, 2012
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide or a pharmaceutically acceptable derivative thereof in the manufacture of a medicament for the treatment of acute exacerbations of chronic obstructive pulmonary disease. Treatment may involve a single dose of the active ingredient by oral administration.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully